PHARMENA SA is a dynamically growing, publicly-held specialty healthcare company, which develops and markets innovative products based on a patented, physiological and natural active substance 1-MNA. The company’s operations focus on clinical research on innovative anti-atherosclerotic medicinal product, production of innovative dermatological products and introduction of innovative dietary supplement used for special nutritional needs in the prevention of atherosclerosis.
|